10 March 2025 : Clinical Research
NSTEMI Risk Prediction with the Combination of the Biomarkers Epicardial Adipose Tissue and Soluble Suppression of Tumorigenicity 2
Jiayu Yin1ACEFG, Bowen Qiu2BCEF, Tingting Li1CE, Yifei Tao3ADE*, Xiaosong Gu1AGDOI: 10.12659/MSM.947019
Med Sci Monit 2025; 31:e947019
Figure 1 Flow diagram of the study cohort. NSTEMI – non-ST-elevation myocardial infarction; PCI – percutaneous coronary intervention; CTA – completed computed tomography angiography; MACEs – major adverse cardiac events; sST2 – soluble suppression of tumorigenicity 2. This figure was generated using Microsoft PowerPoint, Microsoft, Redmond, WA, USA.